XML 81 R22.htm IDEA: XBRL DOCUMENT
v3.19.3

Stock Plans | 12 Months Ended
--- | ---
Aug. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Plans | Note 14. Stock Plans Share based awards may be granted to key employees and directors under the Actuant Corporation 2017 Omnibus Incentive Plan (the “Plan”). At August 31, 2019, 4,325,000 shares of Class A common stock were authorized for issuance under the Plan plus an additional 1,800,000 shares being registered to cover shares, if any, that become issuable, pursuant to the terms of the Plan, upon the expiration, cancellation or forfeiture of existing awards under our previously registered stock plans, of which 3,212,656 shares were available for future award grants. The Plan permits the Company to grant share-based awards, including stock options, restricted stock, restricted stock units and performance shares (the "Performance Shares") to employees and directors. Options generally have a maximum term of ten years, an exercise price equal to 100% of the fair market value of the Company’s common stock at the date of grant and generally vest 50% after three years and 100% after five years. The Company’s restricted stock grants prior to 2017 generally have similar vesting provisions as options while grants thereafter generally vest in equal installments over a three-year period. The Performance Shares include a three-year performance period, with vesting based 50% on achievement of an absolute free cash flow conversion target and 50% on the Company’s total shareholder return ("TSR") relative to the S&P 600 SmallCap Industrial index. The provisions of share-based awards may vary by individual grant with respect to vesting period, dividend and voting rights, performance conditions and forfeitures. A summary of restricted stock and performance shares activity during fiscal 2019 is as follows:
| Number of Shares |  | Weighted-Average Fair Value at Grant Date (Per Share)
Outstanding on August 31, 2018 | 1,153,737 |  |  | $25.25
Granted | 705,602 |  |  | 22.75
Forfeited | (117,899 | ) |  | 24.24
Vested | (460,614 | ) |  | 25.49
Outstanding on August 31, 2019 | 1,280,826 |  |  | $23.87
A summary of stock option activity during fiscal 2019 is as follows:
|  | Shares |  | Weighted-Average Exercise Price (Per Share) |  | Weighted-Average Remaining Contractual Term |  | Aggregate Intrinsic Value
Outstanding on September 1, 2018 |  | 1,769,076 |  |  | $ | 25.40 |  |  |  |  |
Granted |  | — |  |  | — |  |  |  |  |
Exercised |  | (84,277 | ) |  | 19.72 |  |  |  |  |
Forfeited |  | (19,566 | ) |  | 24.44 |  |  |  |  |
Expired |  | (58,690 | ) |  | 20.77 |  |  |  |  |
Outstanding on August 31, 2019 |  | 1,606,543 |  |  | $ | 25.88 |  |  | 4.1 |  | $ | 0.5 | million
Exercisable on August 31, 2019 |  | 1,298,308 |  |  | $ | 26.01 |  |  | 3.5 |  | $ | 0.5 | million
Intrinsic value is the difference between the market value of the stock at August 31, 2019 and the exercise price which is aggregated for all options outstanding and exercisable. A summary of the weighted-average grant-date fair value of options, total intrinsic value of options exercised, and cash receipts from options exercised is summarized below (in thousands, except per share amounts):
| Year Ended August 31,
| 2019 |  | 2018 |  | 2017
Weighted-average fair value of options granted (per share) | N/A |  |  | N/A |  |  | $ | 11.88 |
Intrinsic value of options exercised | $ | 429 |  |  | $ | 5,284 |  |  | 2,208 |
Cash receipts from exercise of options | 1,404 |  |  | 15,140 |  |  | 7,762 |
The Company generally records compensation expense over the vesting period for restricted stock awards based on the market value of the Company's Class A common stock on the grant date and utilized an expected forfeiture rate of 10%, 10% and 11%, for fiscal years ended August 31, 2019, 2018 and 2017, respectively. The fair value of Performance Shares with market vesting conditions is determined utilizing a Monte Carlo simulation model. Stock based compensation expense is determined using a binomial pricing model for options. Assumptions used to determine the fair value of each option were based upon historical data and standard industry valuation practices and methodology. There were no options granted in both fiscal 2019 and 2018. The following weighted-average assumptions were used in fiscal year 2017:
| Fiscal Year Ended August 31, 2017
Dividend yield | 0.15 | %
Expected volatility | 38.12 | %
Risk-free rate of return | 2.42 | %
Expected forfeiture rate | 11 | %
Expected life | 7.4 years |
As of August 31, 2019, there was $18.9 million of total unrecognized compensation cost related to share-based awards, including stock options, restricted stock, restricted stock units and performance shares, which will be recognized over a weighted average period of 1.9 years. The total fair value of share-based awards that vested during the fiscal years ended August 31, 2019 and 2018 was $11.9 million and $14.3 million, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration